Mild and Selective Cooperative-Base Mediated Hydrosilylations for Improved Drug Synthesis
Mild and Selective Cooperative-Base Mediated Hydrosilylations for Improved Drug Synthesis
批准号:
10436072
负责人:
Gregory W O'Neil
金额:
$37.6万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2025-03-31
关键词:
BoronClinicalComplexDevelopmentDrug IndustryDrug usageEpoxy CompoundsEquipmentExposure toFosteringGasesGlycolsGoalsHealthHydrogenHydrogen BondingImidazoleImmunomodulatorsInvestigationMediatingMethodologyMethodsMissionModelingOrganic SynthesisOutcomeParticipantPeriodicityPreparationProcessProtocols documentationPublic HealthReactionReagentReducing AgentsResearchResearch MethodologySafetySilanesSiliconStructureTMEDATestingUnited States National Institutes of HealthUniversitiesWashingtonWaterWorkbaseburden of illnesscostdesigndrug synthesisfunctional grouphazardhuman diseaseimprovednovelnovel therapeuticsnucleophilic additionpressuresuccesstraining opportunitytriethylamineundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
PI: Gregory O’Neil
Western Washington University
Title: Mild and Selective Cooperative-Base Mediated Hydrosilylations for Improved Drug Synthesis
Abstract: Reduction reactions are key transformations in the synthesis of both clinical and experimental drugs
used to treat various human diseases. Common reducing agents, however, can present certain hazards (e.g.
sensitivity to moisture and the release of flammable H2 gas) and/or require special handling and equipment.
Additionally, as the target molecules become more complex, selectivity requirements become more stringent
which drives the need for new easily performed and highly selective reduction protocols. This proposal describes
the use of organosilanes combined with cooperative-base activation to produce a mild, approachable, and
selective reduction method with which to access various biologically active molecules.
Both substrate-controlled diastereoselective hydrosilylations and chiral base-mediated enantioselective
carbonyl reductions will be investigated. The intramolecularity of these reactions is also expected to render the
transformations chemoselective (Aim #1). Regioselective epoxide openings will be accomplished that may
feature newly designed silanes and/or Lewis base activators (Aim #2). All of these reactions are expected to
generate dioxasilinane products that can then be further functionalized to generate valuable synthetic
intermediates that would otherwise be challenging to prepare (Aim #3). This is to be achieved by pursuing the
following specific aims:
1. Explore chemo-, regio-, and diastereoselective cooperative base-mediated intramolecular
hydrosilylations.
2. Perform mechanism-based optimizations of intramolecular hydrosilylations.
3. Investigate functionalization reactions of dioxasilinane intramolecular hydrosilylation products.
This work will have a significant positive impact on providing new and superior access to various important
synthetic intermediates through the combination of predictable selectivity, versatility, and mild reaction
conditions, as well as presenting significant training opportunities for undergraduate participants in various
research methods.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Probing the Archazolid Pharmacophore Using Plant-Based V-ATPase Assays
-
批准号:8290763
-
项目类别:
-
资助金额:$29.03万
-
财政年份:2012
-
负责人:Gregory W O'Neil
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: